Global Exosome Research Market Size 2024, Forecast To 2033
6 Mar, 2024
The exosome research market has experienced exponential growth, soaring from $210.62 billion in 2023 to $283.43 billion in 2024, indicating a compound annual growth rate (CAGR) of 34.6% in the historic period. This growth is linked to the expanding understanding of exosome biology, increased investments in life sciences research, the emergence of liquid biopsies, a heightened focus on personalized medicine, and collaborative research initiatives. Moving forward, the exosome research market is anticipated to witness exponential growth, projecting an increase to $865.26 billion in 2028, sustaining a CAGR of 32.2%. The forecasted period is expected to see continued exponential growth driven by the clinical translation of exosome-based therapeutics, the expansion of liquid biopsy applications, increased collaboration within the industry for research, rising interest in extracellular vesicles (EVs), and a focus on standardization and quality control. Noteworthy trends in the forecast period encompass clinical applications and therapeutics, technological advancements in isolation and analysis, biomarker discovery and diagnostics, and a persistent focus on standardization and quality control, along with collaborations and partnerships.
Global Exosome Research Market Key Driver
The increased incidence of chronic medical diseases is expected to propel the growth of the exosome research market going forward. Chronic diseases typically last three months or longer and can deteriorate over time. Cancer, heart disease, stroke, diabetes, and arthritis are among the most common chronic diseases. It has been demonstrated that infections can use exosome release as a means of infection by altering the exosomes produced by the host to avoid detection by the immune system, thus driving demand for exosome research. Exosomes help to treat various diseases such as cancer, neurodegenerative disorders, and inflammatory conditions. For instance, in July 2022, the Centers for Disease Control and Prevention, a US-based national public health agency defined that every 6 out of 10 Americans have chronic diseases, and 4 out of 10 adults are suffering from more than two chronic diseases, like chronic lung cancer, heart disease, stroke, and diabetes. Therefore, the increased incidence of chronic medical diseases will drive the growth of the exosome research market with market size projections of 2023 reaching X amount, 2024 reaching Y amount, and 2028 reaching Z amount.
Get A Free Sample Of The Global Exosome Research Market ReportGlobal Exosome Research Market Segments
The exosome research market covered in this report is segmented –
1) By Product: Kits And Reagents, Instruments, Other Products
2) By Indication: Cancer, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Other Indications
3) By Application: Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinical Testing Laboratories
By Geography:The regions covered in the exosome research market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the exosome research market in 2023. The regions covered in the exosome research market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Exosome Research Industry Players
Thermo Fisher Scientific Inc., System Biosciences LLC, QIAGEN N.V., Exosome Diagnostics Inc., Bio-Techne Corporation, Hitachi Ltd., Aethlon Medical Inc., NanoSomiX Inc., Malvern Panalytical Ltd., Sistemic Scotland Limited, NX PharmaGen Corporation, Miltenyi Biotec GmbH, AMS Biotechnology (Europe) B.V., Norgen Biotek Corp., Novus Biologicals LLC, Lonza Group AG, Sistem-Bio S.A.S., Izon Science Ltd, Evomic Science LLC, New England Biolabs Inc., Evox Therapeutics Limited, Codiak BioSciences Inc., MagBio Genomics Inc., Cell Guidance Systems Ltd., Aruna Biomedical PBC, CureMetrix Inc., Capricor Therapeutics Inc., Stemcell Technologies Inc., ExoCoBio Inc., Creative Biolabs, ArcherDX Inc., Nanovex Biotechnologies S.L.
Get The Full Global Exosome Research Market Report
Exosome Research Market Overview
Exosomes refer to the smallest EVs (extracellular vesicles) and are of particular interest in the tumor microenvironment (TME), where they have been shown to directly mediate angiogenesis, tumor metastasis, and immunosuppression. EVs can be classified into three main groups based on size, biogenesis, and function.
Exosome Research Global Market Report 2023 provides data on the global exosome research market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The exosome research market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.